2018
DOI: 10.1016/j.ijsu.2018.05.735
|View full text |Cite
|
Sign up to set email alerts
|

Lazaroid (U-74389G) ameliorates lung injury due to lipid peroxidation and nitric oxide synthase-dependent reactive oxygen species generation caused by remote systematic ischemia-reperfusion following thoracoabdominal aortic occlusion

Abstract: Lazaroid U-74389G may represent an effective pharmacologic intervention in reducing lung ischemia-reperfusion injury following thoracoabdominal aortic occlusion.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 29 publications
0
3
0
Order By: Relevance
“…Nitric oxide (NO), a pulmonary vasodilator, is proved to perform vital functions in inhibiting platelet adhesion and maintaining the endothelial structure and function. Endothelin-1 (ET-1) is an endogenous vasoconstrictor peptide that contributes to reducing endothelial injury [31]. In this study, there is no signi cant difference between control group and TEAS group, suggesting that TEAS might have less impact on pulmonary vascular permeability.…”
Section: Discussionmentioning
confidence: 75%
“…Nitric oxide (NO), a pulmonary vasodilator, is proved to perform vital functions in inhibiting platelet adhesion and maintaining the endothelial structure and function. Endothelin-1 (ET-1) is an endogenous vasoconstrictor peptide that contributes to reducing endothelial injury [31]. In this study, there is no signi cant difference between control group and TEAS group, suggesting that TEAS might have less impact on pulmonary vascular permeability.…”
Section: Discussionmentioning
confidence: 75%
“…In a hind limb I/R model in rats, edaravone exert a potent protective effect against lung injury induced through its antioxidant and anti-inflammatory activities [29]. Another animal study has also shown that Lazaroid U-74389G (an anti-lipid peroxidation drug) can reduce lung ischemia-reperfusion injury once the thoracoabdominal aortic occlusion has been relieved [10], and remains an avenue of future research. Second, in a rat model, the remote postconditioning was able to minimize the inflammatory lesion of the lung parenchyma of rats undergoing ischemia and reperfusion process caused by clamping the abdominal aorta [30], which seems more practical in clinical setting than remote-preconditioning.…”
Section: Discussionmentioning
confidence: 99%
“…Previous studies on lung injury after aortic balloon application have mainly been conducted in animals [9,10], or have included a small sample size [11]. Due to the low incidence of pelvic and sacrum tumors, to our knowledge, no study has assessed the incidence of and factors associated with PPCs in patients undergoing pelvic and sacrum tumor resection with abdominal aortic balloon occlusion.…”
Section: Introductionmentioning
confidence: 99%